The company is currently in discussions with several investor groups and plans to use the funds to expand the reach of the test and prepare for FDA submission.
The method combines post-translational modification data and 3D protein structure data to identify known and novel biologically significant hotspots.
Named Helios, the new platform allows for better sampling efficiency and larger sample volumes as well as improved sensitivity and mulitplexing.
The arrangement will join Nuclea's expertise in proteomics with Aelan's genomics know-how.
Intended for diagnosing active pulmonary tuberculosis, the test will use Cere's Nanotrap reagents for enriching target analytes for downstream analysis.
In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.
The American Society of Human Genetics has issued a position statement on genetic testing of children.
The White House seeks to update how biotechnology products are regulated.
Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.